Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00351156 · ClinicalTrials.gov registry record
Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease
A clinical trial, sponsored by Amicus Therapeutics.
- Completed
- Registry status
- 50
- Enrollment target
NCT00351156: Completed study, sponsored by Amicus Therapeutics.
NCT00351156 is a clinical trial that has completed, run by Amicus Therapeutics. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00351156 has completed, sponsored by Amicus Therapeutics.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about Gaucher disease. The information we collect from medical histories and a blood sample from people with Gaucher disease may help us pinpoint certain things that are different between people who have Gaucher disease and people who do not have Gaucher disease. This information may be useful in the future to help find new treatments for Gaucher disease.
Interventions
- PROCEDURE Blood sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-03 |
What the finished NCT00351156 record still lists
NCT00351156 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood sample is the first listed.
NCT00351156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00351156 about?
NCT00351156 is a clinical study titled "Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease". The purpose of this study is to learn more about Gaucher disease. The information we collect from medical histories and a blood sample from people with Gaucher disease may help us pinpoint certain things that are different between people who have Gaucher disease and people who do not have Gaucher di...
What is the current status of trial NCT00351156?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2006-07. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00351156?
The interventions under investigation include: Blood sample (PROCEDURE).
Who is sponsoring clinical trial NCT00351156?
This trial is sponsored by Amicus Therapeutics, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia